Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.14
-0.06 (-1.15%)
At close: Oct 30, 2025, 4:00 PM EDT
5.18
+0.04 (0.78%)
After-hours: Oct 30, 2025, 7:10 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $198.31 million as of October 30, 2025. Its market cap has increased by 428.83% in one year.
Market Cap
198.31M
Enterprise Value
56.65M
1-Year Change
428.83%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has increased from $140.90M to $198.31M, an increase of 40.75%. That is a compound annual growth rate of 3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 200.60M | 84.21% |
| Dec 31, 2024 | 108.90M | 411.27% |
| Dec 29, 2023 | 21.30M | -29.47% |
| Dec 30, 2022 | 30.20M | -60.16% |
| Dec 31, 2021 | 75.80M | -72.07% |
| Dec 31, 2020 | 271.40M | 3,292.50% |
| Dec 31, 2019 | 8.00M | -81.65% |
| Dec 31, 2018 | 43.60M | 30.15% |
| Dec 29, 2017 | 33.50M | 6.35% |
| Dec 30, 2016 | 31.50M | -87.68% |
| Dec 31, 2015 | 255.70M | 49.44% |
| Dec 31, 2014 | 171.10M | 21.43% |
| Oct 22, 2014 | 140.90M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.35B |
| Johnson & Johnson | 453.19B |
| AbbVie | 402.10B |
| UnitedHealth Group | 320.60B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 218.86B |